Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 12, Issue 11 pp 10506—10516

Modification of graphene oxide by angiopep-2 enhances anti-glioma efficiency of the nanoscaled delivery system for doxorubicin

class="figure-viewer-img"

Figure 2. Cellular uptake of Dox, doxorubicin-loaded graphene oxide (Dox-GO) or angiopep-2 polypeptide-modified and doxorubicin-loaded graphene oxide (ANG-Dox-GO) by U87 MG cells. Confocal images of U87 MG cells treated with Dox, Dox-GO or ANG-Dox-GO at 10 μg/mL of Dox for 0.5 and 1 h.